Literature DB >> 21319169

Amyloid neuropathy in a younger domino liver transplanted recipient.

Konen Obayashi, Taro Yamashita, Masayoshi Tasaki, Mitsuharu Ueda, Makoto Shono, Hirofumi Jono, Toshinori Ohshima, Yuki Ohya, Katsuhiro Asonuma, Yukihiro Inomata, Yukio Ando.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21319169     DOI： 10.1002/mus.21941

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  5 in total

Review 1.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 2.  Iatrogenic amyloid polyneuropathy after domino liver transplantation.

Authors:  Diana Mnatsakanova; Saša A Živković
Journal:  World J Hepatol       Date:  2017-01-28

3.  Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.

Authors:  Masaaki Matsushima; Ichiro Yabe; Masaya Tsuda; Mamoru Sakakibara; Tsuyoshi Shimamura; Hidenao Sasaki
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

4.  Normal High HbA1c a Risk Factor for Abnormal Pain Threshold in the Japanese Population.

Authors:  Chieko Itabashi; Hiroki Mizukami; Sho Osonoi; Kazuhisa Takahashi; Kazuhiro Kudo; Kanichiro Wada; Wataru Inaba; Guo Danyang; Chiaki Uchida; Satoko Umetsu; Akiko Igawa; Saori Ogasawara; Masaki Ryuzaki; Kouji Komeda; Yasuyuki Ishibashi; Soroku Yagihashi; Shigeyuki Nakaji
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-02       Impact factor: 5.555

5.  Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy.

Authors:  Velina Nedkova-Hristova; Carmen Baliellas; José González-Costello; Laura Lladó; Emma González-Vilatarsana; Valentina Vélez-Santamaría; Carlos Casasnovas
Journal:  Transpl Int       Date:  2022-04-13       Impact factor: 3.842
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.